Kolexia
Trimoulet Pascale
Pharmacien
Hôpital Pellegrin
Bordeaux, France
65 Activités
536 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite C chronique Hépatite B Infections à VIH Hépatite B chronique Co-infection Carcinome hépatocellulaire Carcinomes

Industries

Gilead
2 collaboration(s)
Dernière en 2022
MSD
1 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Resuming Training in High-Level Athletes After Mild COVID-19 Infection: A Multicenter Prospective Study (ASCCOVID-19).
Sports medicine - open   25 juin 2022
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   15 mars 2022
ASCCOVID19: Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19
Essai Clinique (CHU Bordeaux)   22 juin 2021
Covichem: A biochemical severity risk score of COVID-19 upon hospital admission.
PloS one   06 mai 2021
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World journal of hepatology   30 septembre 2020
No evidence of sexual transmission of HEV among individuals using HIV pre-exposure prophylaxis.
Journal of viral hepatitis   28 septembre 2020
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.
Epidemiology and infection   02 avril 2020
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort.
Antiviral therapy   26 septembre 2019
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   23 novembre 2018
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Viruses   09 juillet 2018